scispace - formally typeset
Journal ArticleDOI

Cytokine networks in neuroinflammation

Reads0
Chats0
TLDR
Recent observations on the impact of dysregulated cytokine networks in neuroinflammation are summarized.
Abstract
Cytokines provide cells with the ability to communicate with one another and orchestrate complex multicellular behaviour. There is an emerging understanding of the role that cytokines play in normal homeostatic tissue function and how dysregulation of these cytokine networks is associated with pathological conditions. The central nervous system (CNS), where few blood-borne immune cells circulate, seems to be particularly vulnerable to dysregulated cytokine networks. In degenerative diseases, such as proteopathies, CNS-resident cells are the predominant producers of pro-inflammatory cytokines. By contrast, in classical neuroinflammatory diseases, such as multiple sclerosis and encephalitides, pro-inflammatory cytokines are mainly produced by tissue-invading leukocytes. Whereas the effect of dysregulated cytokine networks in proteopathies is controversial, cytokines delivered to the CNS by invading immune cells are in general detrimental to the tissue. Here, we summarize recent observations on the impact of dysregulated cytokine networks in neuroinflammation.

read more

Citations
More filters
Journal ArticleDOI

High-Dimensional Single-Cell Mapping of Central Nervous System Immune Cells Reveals Distinct Myeloid Subsets in Health, Aging, and Disease

TL;DR: High‐dimensional cytometry reveals that microglia, several subsets of border‐associated macrophages and dendritic cells coexist in the CNS at steady state and exhibit disease‐specific transformations in the immune microenvironment during aging and in models of Alzheimer’s disease and multiple sclerosis.
Journal ArticleDOI

An Inflammation-Centric View of Neurological Disease: Beyond the Neuron.

TL;DR: This review will describe the current state of knowledge concerning the biology of neuroinflammation, emphasizing mast cell-glia and glia- glia interactions, then conclude with a consideration of how a cell's endogenous mechanisms might be leveraged to provide a therapeutic strategy to target neuro inflammation.
Journal ArticleDOI

The Meningeal Lymphatic System: A New Player in Neurophysiology.

TL;DR: The meningeal lymphatic system can be viewed as a novel player in neurophysiology by altering the accessibility of CSF-borne immune neuromodulators to the brain parenchyma, thereby altering their effects on the brain.
Journal ArticleDOI

Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis

TL;DR: A single-cell characterization of cerebrospinal fluid and blood of newly diagnosed multiple sclerosis patients is provided, revealing altered composition of lymphocyte and monocyte subsets, validated by other methods including the interrogation of the TFH subset in mouse models of MS.
References
More filters
Journal ArticleDOI

The encephalitogenicity of T(H)17 cells is dependent on IL-1- and IL-23-induced production of the cytokine GM-CSF.

TL;DR: Cross-regulation of IL-23 and GM- CSF explains the similar pattern of resistance to autoimmunity when either of the two cytokines is absent and identifies TH17 cells as a crucial source of GM-CSF in autoimmune inflammation.
Journal ArticleDOI

Autoimmune T cell responses in the central nervous system

TL;DR: This Review focuses on recent progress in delineating the pathogenic mechanisms, regulation and interplay between these different T cell subsets in CNS autoimmunity.
Journal ArticleDOI

Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis.

TL;DR: It is shown that APCs of the lymphoreticular system and of the CNS parenchyma are dispensable for the immune invasion of the central nervous system (CNS) and that a discrete population of vessel-associated dendritic cells (DCs) is present in human brain tissue.
Journal ArticleDOI

Demyelination occurring during anti-tumor necrosis factor alpha therapy for inflammatory arthritides.

TL;DR: Until more long-term safety data are available, consideration should be given to avoiding anti-TNFalpha therapy in patients with preexisting multiple sclerosis and to discontinuing anti-Rheumatoid arthritis therapy immediately when new neurologic signs and symptoms occur, pending an appropriate evaluation.
Journal ArticleDOI

IL-34 is a tissue-restricted ligand of CSF1R required for the development of Langerhans cells and microglia

TL;DR: It is found that keratinocytes and neurons were the main sources of IL-34, which specifically directs the differentiation of myeloid cells in the skin epidermis and CNS.
Related Papers (5)

Neuroinflammation in Alzheimer's disease

Michael T. Heneka, +41 more
- 01 Apr 2015 -